Compare FBP & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FBP | HAE |
|---|---|---|
| Founded | 1948 | 1971 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5B | 4.8B |
| IPO Year | 2010 | 1996 |
| Metric | FBP | HAE |
|---|---|---|
| Price | $26.36 | $105.79 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 9 |
| Target Price | $25.50 | ★ $84.13 |
| AVG Volume (30 Days) | ★ 1.1M | 460.8K |
| Earning Date | 04-22-2026 | 05-07-2026 |
| Dividend Yield | ★ 3.36% | N/A |
| EPS Growth | ★ 18.78 | N/A |
| EPS | ★ 1.19 | 0.72 |
| Revenue | ★ $1,255,034,000.00 | $910,373,000.00 |
| Revenue This Year | $15.10 | N/A |
| Revenue Next Year | $4.65 | $5.23 |
| P/E Ratio | ★ $22.03 | $146.50 |
| Revenue Growth | ★ 2.38 | N/A |
| 52 Week Low | $19.16 | $47.75 |
| 52 Week High | $29.88 | $110.45 |
| Indicator | FBP | HAE |
|---|---|---|
| Relative Strength Index (RSI) | 31.13 | 57.94 |
| Support Level | $25.72 | $100.53 |
| Resistance Level | $26.94 | $110.01 |
| Average True Range (ATR) | 0.53 | 2.49 |
| MACD | -0.13 | -0.73 |
| Stochastic Oscillator | 3.90 | 49.90 |
First BanCorp is a financial holding company. The company's operating segment includes Mortgage Banking; Consumer (Retail) Banking; Commercial and Corporate Banking; Treasury and Investments; United States Operations; and Virgin Islands Operations. The Consumer (Retail) Banking segment generates the majority of revenue, which consists of the Corporation's consumer lending and deposit-taking activities conducted mainly through its branch network and loan centres. Geographically, it derives a majority of revenue from Puerto Rico.
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The Plasma segment includes end-to-end collection technologies, automated plasmapheresis systems (such as the NexSys PCS device), and donor management software designed for commercial plasma collectors. Hospital segment includes Blood Management Technologies (hemostasis analyzers, cell salvage systems) and Interventional Technologies. And the Blood Center provides solutions and devices enabling blood centers to harvest essential components like platelets and red blood cells.